RC3H1
Basic information
Region (hg38): 1:173931084-174022357
Links
Phenotypes
GenCC
Source:
- hemophagocytic lymphohistiocytosis, familial, 6 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immune dysregulation and systemic hyperinflammation syndrome | AR | Allergy/Immunology/Infectious | Antibiotics or antiviral agents can be beneficial to treat/prevent infections that can trigger an exaggerated inflammatory response. Chemo/immunotherapy can achieve clinical stability prior to allogeneic hematopoietic cell transplantation (HCT), the only curative therapy. | Allergy/Immunology/Infectious; Craniofacial; Musculoskeletal; Neurologic | 31636267 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RC3H1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 59 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 3 | 1 |
Variants in RC3H1
This is a list of pathogenic ClinVar variants found in the RC3H1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-173938813-T-A | not specified | Uncertain significance (Jan 08, 2025) | ||
1-173938868-A-C | not specified | Uncertain significance (Jul 14, 2021) | ||
1-173941272-T-A | not specified | Uncertain significance (Nov 20, 2024) | ||
1-173941283-T-A | not specified | Uncertain significance (Dec 18, 2024) | ||
1-173941292-G-A | not specified | Uncertain significance (May 30, 2022) | ||
1-173941313-G-C | not specified | Uncertain significance (Jul 08, 2021) | ||
1-173941314-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
1-173941359-T-A | not specified | Uncertain significance (Dec 17, 2024) | ||
1-173943444-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
1-173943468-C-T | not specified | Uncertain significance (Aug 02, 2024) | ||
1-173943484-C-G | not specified | Uncertain significance (Jul 14, 2024) | ||
1-173943505-C-A | not specified | Uncertain significance (Feb 09, 2022) | ||
1-173943521-A-G | not specified | Uncertain significance (Dec 28, 2023) | ||
1-173943545-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
1-173943591-G-C | not specified | Uncertain significance (Jan 24, 2024) | ||
1-173946487-G-A | not specified | Uncertain significance (Feb 22, 2025) | ||
1-173946526-G-C | not specified | Uncertain significance (Jun 02, 2023) | ||
1-173946576-T-C | not specified | Uncertain significance (Nov 09, 2023) | ||
1-173946595-T-C | not specified | Uncertain significance (May 23, 2024) | ||
1-173946821-C-A | not specified | Uncertain significance (Sep 30, 2024) | ||
1-173946833-T-C | not specified | Uncertain significance (Aug 14, 2024) | ||
1-173947386-T-G | not specified | Uncertain significance (Aug 09, 2021) | ||
1-173947390-T-C | not specified | Uncertain significance (Jul 05, 2022) | ||
1-173947392-G-T | not specified | Uncertain significance (Jul 11, 2023) | ||
1-173947411-T-C | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RC3H1 | protein_coding | protein_coding | ENST00000367696 | 19 | 91084 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.993 | 0.00691 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.79 | 431 | 628 | 0.686 | 0.0000331 | 7315 |
Missense in Polyphen | 111 | 233.07 | 0.47626 | 2680 | ||
Synonymous | 1.59 | 192 | 222 | 0.864 | 0.0000113 | 2313 |
Loss of Function | 6.28 | 12 | 67.7 | 0.177 | 0.00000455 | 663 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000148 | 0.000148 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000794 | 0.0000791 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Post-transcriptional repressor of mRNAs containing a conserved stem loop motif, called constitutive decay element (CDE), which is often located in the 3'-UTR, as in HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF, TNFRSF4 and in many more mRNAs (PubMed:25026078). Cleaves translationally inactive mRNAs harboring a stem-loop (SL), often located in their 3'-UTRs, during the early phase of inflammation in a helicase UPF1-independent manner (By similarity). Binds to CDE and promotes mRNA deadenylation and degradation. This process does not involve miRNAs (By similarity). In follicular helper T (Tfh) cells, represses of ICOS and TNFRSF4 expression, thus preventing spontaneous Tfh cell differentiation, germinal center B-cell differentiation in the absence of immunization and autoimmunity (By similarity). In resting or LPS-stimulated macrophages, controls inflammation by suppressing TNF expression (By similarity). Also recognizes CDE in its own mRNA and in that of paralogous RC3H2, possibly leading to feedback loop regulation (By similarity). Recognizes and binds mRNAs containing an hexaloop stem-loop motif, called alternative decay element (ADE) (By similarity). Able to interact with double-stranded RNA (dsRNA) (PubMed:25504471, PubMed:25026078). miRNA-binding protein that regulates microRNA homeostasis. Enhances DICER-mediated processing of pre-MIR146a but reduces mature MIR146a levels through an increase of 3' end uridylation. Both inhibits ICOS mRNA expression and they may act together to exert the suppression (PubMed:25697406). Acts as a ubiquitin E3 ligase. Pairs with E2 enzymes UBE2A, UBE2B, UBE2D2, UBE2F, UBE2G1, UBE2G2 and UBE2L3 and produces polyubiquitin chains (PubMed:26489670). Show the strongest activity when paired with UBE2N:UBE2V1 or UBE2N:UBE2V2 E2 complexes and generate both short and long polyubiquitin chains (PubMed:26489670). {ECO:0000250|UniProtKB:Q4VGL6, ECO:0000269|PubMed:25026078, ECO:0000269|PubMed:25504471, ECO:0000269|PubMed:25697406, ECO:0000269|PubMed:26489670}.;
Intolerance Scores
- loftool
- 0.305
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.57
Haploinsufficiency Scores
- pHI
- 0.377
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.145
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rc3h1
- Phenotype
- digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; respiratory system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); endocrine/exocrine gland phenotype; neoplasm; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- protein polyubiquitination;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;nuclear-transcribed mRNA catabolic process;B cell homeostasis;regulation of germinal center formation;negative regulation of germinal center formation;posttranscriptional regulation of gene expression;negative regulation of B cell proliferation;cytoplasmic mRNA processing body assembly;T cell proliferation;T cell homeostasis;regulation of mRNA stability;negative regulation of T-helper cell differentiation;negative regulation of activated T cell proliferation;lymph node development;spleen development;T cell receptor signaling pathway;regulation of T cell receptor signaling pathway;positive regulation of mRNA catabolic process;3'-UTR-mediated mRNA destabilization;T follicular helper cell differentiation;cellular response to interleukin-1;positive regulation of NIK/NF-kappaB signaling;negative regulation of T-helper 17 cell differentiation;regulation of miRNA metabolic process
- Cellular component
- P-body;cytoplasmic stress granule
- Molecular function
- RNA binding;double-stranded RNA binding;mRNA 3'-UTR binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;miRNA binding;RNA stem-loop binding;ubiquitin protein ligase activity